News
Detailed price information for Astrazeneca Plc Ord (AZNCF) from The Globe and Mail including charting and trades.
Researchers from Thomas Jefferson University have discovered that combining two diabetes drugs—dapagliflozin and ...
3d
Verywell Health on MSNWhat Are Treatment Options for Focal Segmental Glomerulosclerosis (FSGS)?
Medically reviewed by Alexis Appelstein, DO There is no cure for focal segmental glomerulosclerosis (FSGS), but the proper ...
3d
TipRanks on MSNAstraZeneca’s Latest Study on Balcinrenone/Dapagliflozin: Key Insights for Investors
The study tested the effects of balcinrenone/dapagliflozin, a combination drug, in different conditions: fasted, fed, and with the P-gp inhibitor quinidine. The goal was to understand how these ...
Q: I have Type 2 diabetes, and my doctor insists that I give up beverages with almost all sugar substitutes and stick with water. Can you explain what’s wrong with ...
AstraZeneca PLC thrives with $54B revenue and 14 blockbusters in 2024, fueled by oncology and rare disease growth. Click for ...
Akums Drugs and Pharmaceuticals Ltd., India’s largest contract development and manufacturing organization (CDMO), has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results